Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
03/2013
03/14/2013WO2013035827A1 Novel olefin derivative
03/14/2013WO2013035712A1 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis
03/14/2013WO2013034506A1 Pde10 modulators
03/14/2013CA2847624A1 Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof
03/14/2013CA2844652A1 Pde10 modulators
03/13/2013EP2566854A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
03/13/2013EP2566333A1 Identification of stabilizers of multimeric proteins
03/13/2013CN1938244B Fluoridation method
03/13/2013CN102964304A Preparation method of chiral amino cyanide containing pyrazolidone structure
03/13/2013CN102206182B Method for synthesizing Rimonabant hydrochloride
03/13/2013CN101415686B Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors
03/12/2013US8394843 Substituted isoindoles as glucokinase activators
03/12/2013US8394794 Therapeutic compounds
03/07/2013WO2013029338A1 Novel compounds
03/07/2013US20130060041 Synthesis of substituted pyrazoline carboxamidine derivatives
03/07/2013US20130059860 Naphthalene carboxamide m1 receptor positive allosteric modulators
03/06/2013EP2566302A1 Organometallic compounds and emission-shifting organic electrophosphorence
03/06/2013EP2565184A1 Therapeutic agent and preventative agent for alzheimer's disease
03/06/2013EP2564706A1 Anthranilamide insecticides
03/06/2013EP2563765A1 Bicyclic compound derivatives and their use as acc inhibitors.
03/06/2013EP2563759A2 Compounds that modulate intracellular calcium
03/06/2013CN102952076A Preparation of pyrazoline compound and application of pyrazoline compound in anticancer treatment
03/06/2013CN102015627B Amide compounds, preparation methods and uses thereof
03/05/2013USRE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder
03/05/2013US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression
03/05/2013US8389570 Hydroxamates as therapeutic agents
03/05/2013US8389509 Substituted pyrazole compounds
03/05/2013CA2587429C 5-aminopyrazole derivatives as pesticidal compounds
02/2013
02/28/2013US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
02/28/2013US20130053387 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
02/28/2013US20130053386 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
02/28/2013US20130053364 Sulphone Compounds and Methods of Making and Using Same
02/28/2013US20130048505 Plating bath and method
02/27/2013EP2562160A1 Therapeutic agent or preventive agent for urine collection disorder
02/27/2013EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
02/27/2013EP2560962A1 Indazole compounds useful as ketohexokinase inhibitors
02/27/2013EP2560961A1 Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbonyl chlorides and fluorides
02/27/2013EP2560960A1 Process for the preparation of pyrazole carboxylic acid amides
02/27/2013EP2560959A1 Process for the preparation of pyrazole carboxylic acid amides
02/27/2013EP2560958A1 Process for the preparation of pyrazole carboxylic acid amides
02/27/2013EP2560957A1 Process for the preparation of pyrazole carboxylic acid amides
02/27/2013CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2013CN102942526A Novel solid forms of a microbiocide
02/27/2013CN101928246B N-[(1-aryl-3-substituted phenyl-pyrazol-4-yl) methenyl]-2-hydroxyl benzoyl hydrazine compound or pharmaceutically acceptable salts and preparation method thereof
02/26/2013US8383673 Nitridoosmium(VI) complexes for treatment of cancer
02/26/2013US8383664 Crystalline modification of fipronil
02/26/2013US8383654 Heterocyclic antagonists of prostaglandin D2 receptors
02/26/2013US8383622 Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity
02/21/2013WO2013025733A1 Lysophosphatidic acid receptor antagonists
02/21/2013WO2013024898A1 Heterocyclic derivative and pharmaceutical drug
02/21/2013WO2013024171A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
02/21/2013WO2013024170A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
02/21/2013WO2013024004A1 N-thio-anthranilamide compounds and their use as pesticides
02/21/2013WO2013023300A1 Inhibitors of androgen receptor activation function-2 (af2) as therapeutics and methods for their use
02/21/2013US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
02/21/2013US20130045938 Kinase modulators for the treatment of cancer
02/21/2013CA2844982A1 Lysophosphatidic acid receptor antagonists
02/21/2013CA2844794A1 Heterocyclic derivative and pharmaceutical
02/20/2013EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors
02/20/2013CN102939283A Indazole compounds useful as ketohexokinase inhibitors
02/20/2013CN102936222A Compounding method and application of pyrazolone thermochromic compound
02/19/2013US8378118 Pyrazole-based thyroid receptor compounds
02/19/2013US8378117 1-(4-fluoro-phenyl)-8-(4-methyl-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid (1,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amide; antidepressant, anxiolytic; nervous system disorders, metabolic disorders, obesity
02/19/2013US8378096 Hexahydro-cycloheptapyrazole cannabinoid modulators
02/19/2013US8377974 Factor Xa inhibitors
02/19/2013CA2599837C Pyrazolylcarboxanilides
02/19/2013CA2588148C 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
02/14/2013WO2013022047A1 Cyclopropaneamine compound
02/14/2013US20130041161 Process for the preparation of pyrazole carboxylic acid amides
02/14/2013US20130041160 Process for the preparation of pyrazole carboxylic acid amides
02/14/2013US20130041158 Therapeutic agent and preventative agent for alzheimer's disease
02/14/2013US20130041157 Therapeutic agent or preventive agent for urine collection disorder
02/14/2013US20130041147 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
02/14/2013US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/14/2013CA2844525A1 Cyclopropaneamine compound
02/13/2013EP2556749A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
02/13/2013EP2556070A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
02/13/2013CN102933556A N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
02/13/2013CN102933555A Pyrazolecarboxamide derivatives and their use as microbiocides
02/13/2013CN102924377A Synthetic method of 3,4,5-substituted pyrazole compound
02/13/2013CN101296913B Heterocyclic amide derivatives useful as microbiocides
02/12/2013US8372982 Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
02/12/2013US8372844 Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same
02/12/2013US8372822 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
02/12/2013CA2596527C Igf-1r inhibitors
02/12/2013CA2543054C Isopentylcarboxanilides for combating undesired micro-organisms
02/07/2013WO2013017654A1 Novel estrogen receptor ligands
02/07/2013US20130035496 Process for the preparation of pyrazole carboxylic acid amides
02/07/2013US20130035495 Process for the preparation of pyrazole carboxylic acid amides
02/07/2013US20130035325 Kinase inhibitors
02/07/2013US20130035312 Cathepsin cysteine protease inhibiors
02/07/2013CA2842719A1 Novel estrogen receptor ligands
02/06/2013EP2554541A1 Therapeutic agent or prophylactic agent for fibromyalgia
02/06/2013EP2552895A1 Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines
02/06/2013CN102918028A N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues
02/06/2013CN102915834A Positive charge storage material for all-solid-state electrical energy storage devices
02/06/2013CN102911119A Preparation methods of 3,4-dimethyl pyrazole and 3,4-dimethyl pyrazole phosphate
02/05/2013US8367846 Method of producing 2-alkyl-3-aminothiophene derivative
02/05/2013US8367844 Microbiocidal heterocycles
02/05/2013US8367828 PPAR active compounds
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 256